期刊文献+

心血管介入治疗中造影剂肾病防治的研究进展 被引量:27

Research Progress in Contrast-induced Nephropathy in Cardiovascular Intervention
下载PDF
导出
摘要 造影剂肾病是应用造影剂后的一种急性肾损伤,目前是院内急性肾衰竭的第3大病因,造影剂所造成的危害日益引起医学界的关注。造影剂肾病的防治手段包括术前停止使用肾毒性药物、严格掌握造影适应证、合理使用对比剂、水化治疗等,常用药物有N-乙酰半胱氨酸、腺苷受体抑制剂、他汀类药物等。现就近几年造影剂肾病的防治方法予以综述。 Contrast-induced nephropathy(CIN)is an acute renal injury secondary to the use of contrast media,as the third cause of nosocomial acute renal failure.The threats posed by contrast media are increasingly attended by clinicians.The prophylactic measures of CIN include the termination of nephrotoxic drugs,strict indication of use,appropriate use of contrast media,and rehydration.The commonly used drugs consist of N-acetylcysteine,adenosine receptor inhibitor,and statins.This article reviews the prophylactic measures of CIN.
出处 《医学综述》 2011年第2期234-236,共3页 Medical Recapitulate
关键词 造影剂肾病 防治 方法 Contrast-induced nephropathy Prophylaxis Methods
  • 相关文献

参考文献3

二级参考文献33

  • 1Aspelin P.Nephrotoxicity and the role of contrast media.Radiat Med,2004,22:377-378.
  • 2Nash K,Hafeez A,Hou S.Hospital-acquired renal insufficiency.Am J Kidney Dis,2002,39:930-936.
  • 3Taylor AJ,Hotehkiss D,Morse RW,et al.PREPARED:Preparation for Angiography in Renal Dysfunction:a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction.Chest,1998,114:1570-1574.
  • 4Mueller C,Buerkle G,Buettner HJ,et al.Prevention of contrast media-associated nephropathy:randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.Arch Intern Med,2002,162:329-336.
  • 5Shepherd J,Kastelein JJ,Bittner V,et al.Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease:the Treating to New Targets (TNT) study.Clin J Am Soc Nephrol,2007,2:1131-1139.
  • 6王笑云.肾小球功能检查//陈文彬,潘祥林.诊断学.6版.北京:人民卫生出版社,2004:379
  • 7Chello M,Goffredo C,Patti G,Effects of atorvestatin on arterial endothelial function in coronary bypass surgery.Eur J Cardiothorac Surg,2005,28:805-810.
  • 8Patti G,Nusea A,Chello M,et al.Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing pereutaneous coronary intervention.Am J Cardiol,2008,101:279-285.
  • 9Dulak J,Loboda A,Jazwa A.Atorvastatin affects several angiogenic mediators in human endothelial cells.Endothelium,2005,12:233-241.
  • 10Bonnet J,McPherson R,Tedgui A,et al.Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease:results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.Clin Ther,2008,30:2298-2313.

共引文献57

同被引文献267

引证文献27

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部